Published in Eksp Klin Farmakol on December 17, 2001
Involvement of Mu Opioid Receptor Signaling in the Protective Effect of Opioid against 6-Hydroxydopamine-Induced SH-SY5Y Human Neuroblastoma Cells Apoptosis. Basic Clin Neurosci (2015) 0.75
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists. Med Res Rev (2016) 0.75
Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech (1999) 1.82
Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology (1997) 1.75
Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J Mol Cell Cardiol (2001) 1.70
Opioids and cardioprotection. Pharmacol Ther (2001) 1.53
BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol (2001) 1.51
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res (1992) 1.40
Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol (2000) 1.29
Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol (1986) 1.27
Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res (1996) 1.24
Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol (1993) 1.24
Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol (2001) 1.22
Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res (2001) 1.20
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res (1999) 1.20
Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol (1997) 1.18
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience (2004) 1.17
Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection? Am J Physiol Heart Circ Physiol (2000) 1.15
Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation (1994) 1.14
Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem (2001) 1.13
Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol (1988) 1.13
Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther (2000) 1.11
Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences. Am J Physiol Heart Circ Physiol (2001) 1.09
Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther (2001) 1.09
Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist. J Pharmacol Exp Ther (1981) 1.09
Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol (1995) 1.08
Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts. Am J Physiol Heart Circ Physiol (2001) 1.07
Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat Rec (2001) 1.06
A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels. Circulation (1994) 1.00
TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol (1998) 1.00
Effects of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol (1984) 1.00
Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology (1996) 1.00
Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res (1993) 0.99
Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation (1998) 0.99
ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol (2001) 0.99
Preconditioning in immature rabbit hearts: role of KATP channels. Circulation (1999) 0.99
Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation (1992) 0.99
Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol (1998) 0.98
The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol (1997) 0.98
The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther (1991) 0.98
Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol (2001) 0.98
PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res (1996) 0.97
The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int (2009) 0.97
Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res (1999) 0.96
Beta adrenergic blockade on intramyocardial distribution of coronary blood flow. J Pharmacol Exp Ther (1973) 0.96
Coronary steal in four models of single or multiple vessel obstruction in dogs. Am J Cardiol (1981) 0.95
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation (1995) 0.95
Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. J Pharmacol Exp Ther (1981) 0.94
Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol (2001) 0.94
Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation (2000) 0.94
Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract (2001) 0.94
Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector. Anal Biochem (1996) 0.94
A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J Pharmacol Exp Ther (1998) 0.94
Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res (1993) 0.93
Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium. Circulation (1993) 0.92
Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology (2000) 0.92
Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol (1992) 0.91
Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res Cardiol (2005) 0.91
Alteration in oxyhemoglobin equilibrium (P-50) and myocardial oxygen consumption (MVO2) by nitroglycerin (GTN). J Pharmacol Exp Ther (1975) 0.91
Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res (1988) 0.91
Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes. J Pharmacol Exp Ther (1994) 0.90
Sarcolemmal and mitochondrial K(ATP) channels and myocardial ischemic preconditioning. J Cell Mol Med (2003) 0.90
Effect of propranolol on regional myocardial blood flow and oxygen consumption. J Pharmacol Exp Ther (1976) 0.90
Effects of pentylenetetrazol on ion transport in the isolated toad bladder. J Pharmacol Exp Ther (1972) 0.90
Beneficial effects of iloprost in the stunned canine myocardium. Circ Res (1988) 0.89
Increased tolerance of the chronically hypoxic immature heart to ischemia. Contribution of the KATP channel. Circulation (1997) 0.89
Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol (1985) 0.89
Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res (2000) 0.89
Mitochondrial K(ATP) channels: triggers or distal effectors of ischemic or pharmacological preconditioning? Circ Res (2000) 0.88
Effect of ortho-iodo sodium benzoate on hemoglobin-oxygen affinity in normal and ischemic myocardium. J Pharmacol Exp Ther (1977) 0.88
Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation (1996) 0.88
Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics? Circ Res (2000) 0.87
Determination of experimental myocardial infarct size. J Pharmacol Methods (1981) 0.87
Nitric oxide activates the sarcolemmal K(ATP) channel in normoxic and chronically hypoxic hearts by a cyclic GMP-dependent mechanism. J Mol Cell Cardiol (2001) 0.87
Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther (1992) 0.87
Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol (1999) 0.87
Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol (1993) 0.86
Time course of recovery of "stunned" myocardium following variable periods of ischemia in conscious and anesthetized dogs. Am Heart J (1987) 0.86
Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res (1995) 0.86
Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs. J Cardiovasc Pharmacol (1984) 0.85
Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs. Basic Res Cardiol (1985) 0.85
Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium. Am J Cardiol (1979) 0.85
Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol (1997) 0.85
Mechanism of coronary vasodilation produced by bradykinin. Circulation (1991) 0.85
Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol (2001) 0.84
The ATP-dependent potassium channel: an endogenous cardioprotective mechanism. J Cardiovasc Pharmacol (1994) 0.84
Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs. J Cardiovasc Pharmacol (1993) 0.84
Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology (1997) 0.84
Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol (2000) 0.84
Na(+)/H(+) exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes. Am J Physiol Heart Circ Physiol (2000) 0.84
Analysis of coronary vascular beta receptors in situ. Am J Physiol (1975) 0.84
Coronary steal-induced increase in myocardial infarct size after pharmacologic coronary vasodilation. Am J Cardiol (1980) 0.84
Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection. Anesthesiology (1998) 0.83
Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs. Anesthesiology (1987) 0.83
Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model. J Pharmacol Exp Ther (1984) 0.83
Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway. J Pharmacol Exp Ther (2001) 0.83
Transmural distribution of blood flow during activation of coronary muscarinic receptors. Am J Physiol (1981) 0.83
Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol (1997) 0.83
Monophosphoryl lipid A protects against endotoxic shock via inhibiting neutrophil infiltration and preventing disseminated intravascular coagulation. Circ Shock (1994) 0.83
Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosis. Am Heart J (1988) 0.83
Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Cardiovasc Res (1996) 0.82
Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rat. Mol Cell Biochem (1993) 0.82